» Articles » PMID: 29515655

Cauda Equina Syndrome Secondary to Leptomeningeal Metastases from Recurrent Primary Peritoneal Carcinoma

Overview
Specialty Oncology
Date 2018 Mar 9
PMID 29515655
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The patient is a 42-year-old woman with metastatic primary peritoneal carcinoma and known brain metastases, who subsequently developed cauda equina syndrome after presenting with ataxia, lower extremity weakness, and bowel and bladder incontinence secondary to leptomeningeal metastasis after treatment with neoadjuvant chemotherapy, surgical debulking, and adjuvant chemotherapy. Metastases to the central nervous system (CNS) and leptomeninges are rare events in epithelial ovarian and primary peritoneal carcinomas as these tumours do not have a predilection for the CNS. Cauda equina syndrome is often characterised by gait disturbances, bowel and bladder dysfunction, saddle anaesthesia, and lower extremity muscle weakness. In patients with known metastatic gynaecologic carcinomas presenting with nonspecific neurologic symptoms, cauda equina syndrome should remain high in the differential diagnosis.

Citing Articles

Neoplastic nerve lesions.

Patel D, Gwathmey K Neurol Sci. 2022; 43(5):3019-3038.

PMID: 35195810 DOI: 10.1007/s10072-022-05951-x.


Cauda equina syndrome due to leptomeningeal carcinomatosis: a medical dilemma.

Izadi Firouzabadi L, Mead P, Berry J, Hanif S BMJ Case Rep. 2020; 13(2).

PMID: 32019757 PMC: 7021131. DOI: 10.1136/bcr-2019-232297.

References
1.
Hong S, Lee S, Kim H, Lee H, Jung K, Lee S . Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10. Gynecol Oncol. 2014; 136(2):212-7. DOI: 10.1016/j.ygyno.2014.11.017. View

2.
Miettinen M, McCue P, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K . GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2013; 38(1):13-22. PMC: 3991431. DOI: 10.1097/PAS.0b013e3182a0218f. View

3.
Goto Y, Katsumata N, Nakai S, Sasajima Y, Yonemori K, Kouno T . Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate. Int J Clin Oncol. 2008; 13(6):555-8. DOI: 10.1007/s10147-008-0782-2. View

4.
Gressel G, Lundsberg L, Altwerger G, Katchi T, Azodi M, Schwartz P . Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature. Int J Gynecol Cancer. 2015; 25(9):1711-6. PMC: 4623851. DOI: 10.1097/IGC.0000000000000554. View

5.
Espinosa I, Gallardo A, DAngelo E, Mozos A, Lerma E, Prat J . Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases. Int J Gynecol Pathol. 2015; 34(3):257-65. DOI: 10.1097/PGP.0000000000000155. View